These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Dysferlin mediates the cytoprotective effects of TRAF2 following myocardial ischemia reperfusion injury. Tzeng HP; Evans S; Gao F; Chambers K; Topkara VK; Sivasubramanian N; Barger PM; Mann DL J Am Heart Assoc; 2014 Feb; 3(1):e000662. PubMed ID: 24572254 [TBL] [Abstract][Full Text] [Related]
3. TRAF2 differentially regulates the canonical and noncanonical pathways of NF-kappaB activation in mature B cells. Grech AP; Amesbury M; Chan T; Gardam S; Basten A; Brink R Immunity; 2004 Nov; 21(5):629-42. PubMed ID: 15539150 [TBL] [Abstract][Full Text] [Related]
4. TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NF-kappaB pathway by TRAF-binding TNFRs. Hauer J; Püschner S; Ramakrishnan P; Simon U; Bongers M; Federle C; Engelmann H Proc Natl Acad Sci U S A; 2005 Feb; 102(8):2874-9. PubMed ID: 15708970 [TBL] [Abstract][Full Text] [Related]
5. TNFα induced noncanonical NF-κB activation is attenuated by RIP1 through stabilization of TRAF2. Kim JY; Morgan M; Kim DG; Lee JY; Bai L; Lin Y; Liu ZG; Kim YS J Cell Sci; 2011 Feb; 124(Pt 4):647-56. PubMed ID: 21266470 [TBL] [Abstract][Full Text] [Related]
6. The pivotal role of the alternative NF-kappaB pathway in maintenance of basal bone homeostasis and osteoclastogenesis. Soysa NS; Alles N; Weih D; Lovas A; Mian AH; Shimokawa H; Yasuda H; Weih F; Jimi E; Ohya K; Aoki K J Bone Miner Res; 2010 Apr; 25(4):809-18. PubMed ID: 19839765 [TBL] [Abstract][Full Text] [Related]
8. Despite inhibition of nuclear localization of NF-kappa B p65, c-Rel, and RelB, 17-beta estradiol up-regulates NF-kappa B signaling in mouse splenocytes: the potential role of Bcl-3. Dai R; Phillips RA; Ahmed SA J Immunol; 2007 Aug; 179(3):1776-83. PubMed ID: 17641044 [TBL] [Abstract][Full Text] [Related]
9. NFkappaB1/p50 is not required for tumor necrosis factor-stimulated growth of primary mammary epithelial cells: implications for NFkappaB2/p52 and RelB. Zhang J; Warren MA; Shoemaker SF; Ip MM Endocrinology; 2007 Jan; 148(1):268-78. PubMed ID: 17008396 [TBL] [Abstract][Full Text] [Related]
11. Control of RelB during dendritic cell activation integrates canonical and noncanonical NF-κB pathways. Shih VF; Davis-Turak J; Macal M; Huang JQ; Ponomarenko J; Kearns JD; Yu T; Fagerlund R; Asagiri M; Zuniga EI; Hoffmann A Nat Immunol; 2012 Dec; 13(12):1162-70. PubMed ID: 23086447 [TBL] [Abstract][Full Text] [Related]
12. RelB/p52 NF-kappaB complexes rescue an early delay in mammary gland development in transgenic mice with targeted superrepressor IkappaB-alpha expression and promote carcinogenesis of the mammary gland. Demicco EG; Kavanagh KT; Romieu-Mourez R; Wang X; Shin SR; Landesman-Bollag E; Seldin DC; Sonenshein GE Mol Cell Biol; 2005 Nov; 25(22):10136-47. PubMed ID: 16260626 [TBL] [Abstract][Full Text] [Related]
13. Nuclear factor-kappaB protects the adult cardiac myocyte against ischemia-induced apoptosis in a murine model of acute myocardial infarction. Misra A; Haudek SB; Knuefermann P; Vallejo JG; Chen ZJ; Michael LH; Sivasubramanian N; Olson EN; Entman ML; Mann DL Circulation; 2003 Dec; 108(25):3075-8. PubMed ID: 14676146 [TBL] [Abstract][Full Text] [Related]
14. Cardioprotective Role of Tumor Necrosis Factor Receptor-Associated Factor 2 by Suppressing Apoptosis and Necroptosis. Guo X; Yin H; Li L; Chen Y; Li J; Doan J; Steinmetz R; Liu Q Circulation; 2017 Aug; 136(8):729-742. PubMed ID: 28572508 [TBL] [Abstract][Full Text] [Related]
15. TRAF2 plays a key, nonredundant role in LIGHT-lymphotoxin beta receptor signaling. Kim YS; Nedospasov SA; Liu ZG Mol Cell Biol; 2005 Mar; 25(6):2130-7. PubMed ID: 15743811 [TBL] [Abstract][Full Text] [Related]
16. Methods to assess the activation of the alternative (noncanonical) NF-κB pathway by non-death TNF receptors. Remouchamps C; Dejardin E Methods Mol Biol; 2015; 1280():103-19. PubMed ID: 25736746 [TBL] [Abstract][Full Text] [Related]
17. A roadmap of constitutive NF-κB activity in Hodgkin lymphoma: Dominant roles of p50 and p52 revealed by genome-wide analyses. de Oliveira KA; Kaergel E; Heinig M; Fontaine JF; Patone G; Muro EM; Mathas S; Hummel M; Andrade-Navarro MA; Hübner N; Scheidereit C Genome Med; 2016 Mar; 8(1):28. PubMed ID: 26988706 [TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) promotes glioma cell invasion through induction of NF-κB-inducing kinase (NIK) and noncanonical NF-κB signaling. Cherry EM; Lee DW; Jung JU; Sitcheran R Mol Cancer; 2015 Jan; 14(1):9. PubMed ID: 25622756 [TBL] [Abstract][Full Text] [Related]
19. TNFR2 increases the sensitivity of ligand-induced activation of the p38 MAPK and NF-κB pathways and signals TRAF2 protein degradation in macrophages. Ruspi G; Schmidt EM; McCann F; Feldmann M; Williams RO; Stoop AA; Dean JL Cell Signal; 2014 Apr; 26(4):683-90. PubMed ID: 24378531 [TBL] [Abstract][Full Text] [Related]
20. Evidence that TNF-TNFR1-TRADD-TRAF2-RIP-TAK1-IKK pathway mediates constitutive NF-kappaB activation and proliferation in human head and neck squamous cell carcinoma. Jackson-Bernitsas DG; Ichikawa H; Takada Y; Myers JN; Lin XL; Darnay BG; Chaturvedi MM; Aggarwal BB Oncogene; 2007 Mar; 26(10):1385-97. PubMed ID: 16953224 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]